Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2003
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667334 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
12/23/2003US6667330 Cytoprotective; neuroinflammation and neurodegenerative disorders; oxidative stress related conditions
12/23/2003CA2149207C Compounds that inhibit t cell proliferation and methods using the same
12/18/2003WO2003104265A1 Compound having glycine transporter inhibition activity
12/18/2003WO2003104243A1 Chemical synthesis of reagents for peptide coupling
12/18/2003WO2003104235A1 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]pyrazines and decahydropyrazino[1,2-a]azepines
12/18/2003WO2003104217A2 Prodrugs of excitatory amino acids
12/18/2003WO2003104196A1 Non-peptidic brs-3 agonists
12/18/2003WO2003104184A1 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs
12/18/2003WO2003104167A2 Cyanohydrin ethers and esters as high-sensitivity enzyme substrates
12/18/2003WO2003103718A2 Intracellular delivery of biological effectors
12/18/2003WO2003103677A1 Derivatives of azepine and thiazeran as interleukin converting enzyme inhibitors
12/18/2003WO2003103656A1 O-substituted hydroxyaryl derivatives
12/18/2003WO2002092781A3 Peptide compounds for counteracting reactive oxygen species and free radicals
12/18/2003US20030232986 Inhibitors of caspases
12/18/2003US20030232966 For treatment of encephalomyelitis, leukodystrophy, adrenoleukodystrophy, migraines, epilepsy, Alzheimer's/Parkinson's diseases, and neuron diseases
12/18/2003US20030232873 Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)
12/18/2003US20030232806 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them
12/18/2003US20030232788 Inhibitors of interleukin-1 beta converting enzyme and related proteases
12/18/2003US20030232762 Therapeutic treating breast cancer
12/18/2003US20030232742 A peptide containing residue of cytotoxic or cytostatic compound
12/18/2003US20030232334 Novel compositions and methods for cancer
12/18/2003US20030232053 Administering to treat rheumatoid arthritis, cancer, restenosis
12/18/2003CA2790348A1 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin f2.alpha. receptor
12/18/2003CA2497609A1 Non-peptidic brs-3 agonists
12/18/2003CA2489186A1 Chemical synthesis of reagents for peptide coupling
12/18/2003CA2488716A1 Intracellular delivery of biological effectors
12/17/2003EP1371659A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts [2003/26]
12/17/2003EP1370276A2 Medical uses of intercellular communication facilitating compounds
12/17/2003EP1370211A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
12/17/2003EP1224210B1 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them
12/17/2003EP1157031B1 Oligomers substituted by phosphonic acid ester, phosphonic acid or carbaborane functions and the corresponding pna monomers
12/17/2003EP1129107B1 Method for producing l-prolyl-l-m-sarcolysyl-l-p-fluorophenylalanine and derivatives thereof
12/17/2003EP1115414B1 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester
12/17/2003EP1009420B1 Conjugates useful in the treatment of prostate cancer
12/17/2003EP0984981B1 Anti-inflammatory tyrosine derivatives
12/17/2003EP0839154B1 Biologically active peptides and compositions, their use
12/17/2003CN1462277A Pharmaceutical composition comprising analgesic peptide
12/17/2003CN1130989C Sweetener compositions
12/16/2003US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
12/16/2003US6664255 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
12/16/2003US6663887 Compounds and compositions for delivering active agents
12/16/2003CA2195125C Difluorostatone antiviral agents
12/16/2003CA2088788C Peptides that block human immunodeficiency virus infections and methods of use thereof
12/11/2003WO2003102579A2 Method of screening groups of radioactive molecules and applications thereof
12/11/2003WO2003102207A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
12/11/2003WO2003102195A1 Protein hydrolysate rich in tripeptides
12/11/2003WO2003101578A1 Production of crystalline materials by using high intensity ultrasound
12/11/2003WO2003101577A1 Production of crystalline materials by using high intensity ultrasound
12/11/2003WO2003101391A2 Therapeutic methods
12/11/2003WO2003084984A8 Heterocyclic amides with alpha-4 integrin antagonist activity
12/11/2003WO2003059877A3 Novel affinity labels
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003040288A3 Isotopically coded affinity markers 3
12/11/2003WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
12/11/2003WO2003029292A3 Gene regulatory peptides
12/11/2003WO1999024553A3 X-ray crystal comprising hiv-1 gp120
12/11/2003US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors
12/11/2003US20030229254 Process for the preparation of 3, 3-dimethylbutanal
12/11/2003US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders
12/11/2003US20030229205 Silver halide emulsion for improving photographic products such as photographic paper or cellulose films
12/11/2003US20030229200 Useful in treating or preventing obesity
12/11/2003US20030229120 Zinc binding ligand; sustained release of insulin
12/11/2003US20030229024 Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/11/2003US20030229019 Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof
12/11/2003US20030229014 Agents and methods for promoting bone growth
12/11/2003US20030228371 Anti-infarction molecules
12/11/2003US20030228353 Wound heraling agents; polypeptide
12/11/2003CA2486911A1 Method of screening groups of radioactive molecules and applications thereof
12/11/2003CA2485199A1 Production of crystalline materials by using high intensity ultrasound
12/10/2003EP1369425A1 Thiopeptide compounds
12/10/2003EP1368371A2 Transfection complexes
12/10/2003EP1368064A2 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
12/10/2003EP1123410B1 The enzyme-mediated synthesis of peptidomimetics
12/10/2003EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
12/10/2003EP1058687B1 Nucleosides
12/10/2003EP0932618B1 Peptide analogues containing a 7-membered lactam ring
12/10/2003EP0671924B1 Digitalis-like compounds
12/10/2003CN1130371C Method for preparing aspartame salt from N-protected aspartame
12/10/2003CN1130347C 2,3-methylene amino acid compounds, their preparing method and pharmaceutical composition containing them
12/09/2003US6660845 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
12/09/2003US6660741 Coupling an O-protected methoxypyrrolidine or derivatives with N-protected amino acid 2,5-dioxo-pyrrolidinyl ester to form intermediate, deportecting with trifluoroacetic acid to form pyrrolidine-1-carbonyl-2-methylamine or derivatives
12/09/2003US6660268 Proteasome regulation of NF-KB activity
12/09/2003CA2078758C 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
12/04/2003WO2003099853A2 Petide amidation process
12/04/2003WO2003099787A1 Novel piperidine compound
12/04/2003WO2003099780A2 Luminogenic protease substrates
12/04/2003WO2003099338A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/04/2003WO2003099316A1 Heterocyclicsulfonamide hepatitis c virus inhibitors
12/04/2003WO2003099315A1 A pharmaceutical composition comprising a retro-iverso isomer peptide
12/04/2003WO2003099274A1 Hepatitis c virus inhibitors
12/04/2003WO2003099202A2 Beta-secretase inhibitors
12/04/2003WO2003066673A8 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
12/04/2003WO2003050540A3 Flexible method and apparatus for high throughput production and purification of multiple proteins
12/04/2003WO2002073208A3 Anti-epileptogenic agents
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225280 2-Amino-N-(1(R)-benzvloxymethyl-2-(1,3-dioxo-8a(S)-pyridin-2-y lmethyl-2-(2,2,2-trifluoro-ethyl)-hexahydroimidazo(1,5-a)pyraz in-7-yl)-2-oxo- ethyl)-2-methyl-propionamide chloride from piperazine-2-carboxylate esters
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225115 Anticoagulants
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 307